Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models

Author:

Khalid Sara1ORCID,Pineda‐Moncusí Marta2ORCID,El‐Hussein Leena1,Delmestri Antonella1,Ernst Martin3,Smith Christopher3,Libanati Cesar4ORCID,Toth Emese4,Javaid Muhammad K1ORCID,Cooper Cyrus15,Abrahamsen Bo1367,Prieto‐Alhambra Daniel1589

Affiliation:

1. Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Nuffield Orthopaedic Centre University of Oxford Oxford UK

2. IMIM (Hospital del Mar Research Institute), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Barcelona Spain

3. Department of Public Health, Clinical Pharmacology, and Pharmacy University of Southern Denmark Odense Denmark

4. UCB Biopharma Sprl Brussels Belgium

5. MRC Lifecourse Epidemiology Unit University of Southampton, Southampton General Hospital Southampton UK

6. Open Patient Data Explorative Network University of Southern Denmark and Odense University Hospital Odense Denmark

7. Department of Medicine Holbæk Hospital Holbæk Denmark

8. Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gorina (IDIAPJ Gol), CIBERFES Barcelona Spain

9. Universitat Autònoma de Barcelona Bellaterra Spain

Funder

UCB UK

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference43 articles.

1. Osteoporosis in the European Union: a compendium of country-specific reports

2. Fragility fractures in Europe: burden, management and opportunities

3. International Osteoporosis Foundation. Broken bones broken lives: a roadmap to solve the fragility fracture crisis in Europe. 2018. Available at:https://www.iofbonehealth.org/broken-bones-broken-lives. Accessed December 10 2020.

4. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

5. Treat-to-target for Osteoporosis: Is Now the Time?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3